The Intermediate Tuberal Nucleus (ITN) is a hypothalamic nucleus located in the tuberal region that plays essential roles in energy homeostasis, feeding behavior, and metabolic regulation. This nucleus has gained attention for its involvement in neurodegenerative diseases where metabolic dysfunction is a recognized feature. [1]
The ITN occupies a strategic position within the tuberal hypothalamus, adjacent to the arcuate nucleus and ventromedial hypothalamus. It integrates metabolic signals and coordinates responses to maintain energy balance [1]. [2]
| Property | Value | [3]
|----------|-------| [4]
| Category | Hypothalamic Tuberal Nuclei | [5]
| Location | Tuberal hypothalamus |
| Primary function | Metabolic regulation |
| Key connections | Arcuate nucleus, VMH, brainstem |
Neuronal types:
Glial cells:
The ITN receives information from:
Outputs regulate:
| Marker | Expression | Significance |
|---|---|---|
| NPY | High | Feeding stimulation |
| POMC | Moderate | Feeding inhibition |
| GABA | High | Primary neurotransmitter |
| Leptin R | Moderate | Metabolic sensing |
| ghrelin R | Low | Hunger signaling |
The ITN is a critical component of the metabolic regulatory network:
The ITN influences autonomic function through:
Metabolic dysfunction is increasingly recognized in AD:
PD involves hypothalamic dysfunction:
ALS shows metabolic components:
HD has prominent metabolic features:
Prion diseases affect hypothalamic function:
Understanding ITN involvement offers therapeutic opportunities:
Potential targets:
](/cell-types/arcuate-nucleus
--ventromedial-hypothalamus
--dorsomedial-hypothalamus
--suprachiasmatic-nucleus
--hypothalamic-neurons-in-neurodegeneration)## Background
The study of Intermediate Tuberal Nucleus (Itn) Neurons has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Elmquist JK, Maratos-Flier E, Saper CB, Flier JS. Unraveling the central nervous system pathways underlying responses to leptin. Nat Neurosci. 1998. 1998. ↩︎
Hofman MA, Swaab DF. The human hypothalamus: comparative morphometry and photoperiodic influences. Prog Brain Res. 1992. 1992. ↩︎
Ma JO, Jankovic J. Metabolic aspects of Parkinson's disease. Mov Disord. 2020. 2020. ↩︎
Dupuis L, Pradat PF, Ludolph AC, Loeffler JP. Energy metabolism in amyotrophic lateral sclerosis. Lancet Neurol. 2011. 2011. ↩︎
van der Burg JMM, Bacos K, Wood NI, et al. Improved metabolic support in a mouse model of Huntington's disease. J Neurochem. 2022. 2022. ↩︎